Drug Farm

Lisbon, Portugal – March 26, 2026 Abcuro presented results from its Phase 2/3 MUSCLE clinical trial evaluating ulviprubart (ABC008)...

Albany, USA & Shanghai, China – March 26, 2026 Drug Farm announced that the U.S. Food and Drug Administration...